Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Solution structure of the fibrin binding finger domain of tissue-type plasminogen activator determined by 1H nuclear magnetic resonance.

Downing AK, Driscoll PC, Harvey TS, Dudgeon TJ, Smith BO, Baron M, Campbell ID.

J Mol Biol. 1992 Jun 5;225(3):821-33.

PMID:
1602484
3.

Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.

Bakker AH, Nieuwenbroek NM, Verheijen JH.

Protein Eng. 1995 Dec;8(12):1295-1302.

PMID:
8869642
4.

High-resolution three-dimensional structure of a single zinc finger from a human enhancer binding protein in solution.

Omichinski JG, Clore GM, Appella E, Sakaguchi K, Gronenborn AM.

Biochemistry. 1990 Oct 9;29(40):9324-34.

PMID:
2248949
6.

Solution structure of recombinant hirudin and the Lys-47----Glu mutant: a nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study.

Folkers PJ, Clore GM, Driscoll PC, Dodt J, Köhler S, Gronenborn AM.

Biochemistry. 1989 Mar 21;28(6):2601-17.

PMID:
2567183
7.

Secondary structure of fibronectin type 1 and epidermal growth factor modules from tissue-type plasminogen activator by nuclear magnetic resonance.

Smith BO, Downing AK, Dudgeon TJ, Cunningham M, Driscoll PC, Campbell ID.

Biochemistry. 1994 Mar 8;33(9):2422-9.

PMID:
8117702
8.

Solution structure of the kringle domain from urokinase-type plasminogen activator.

Li X, Bokman AM, Llinás M, Smith RA, Dobson CM.

J Mol Biol. 1994 Feb 4;235(5):1548-59.

PMID:
8107091
9.
11.

High-resolution solution structure of reduced French bean plastocyanin and comparison with the crystal structure of poplar plastocyanin.

Moore JM, Lepre CA, Gippert GP, Chazin WJ, Case DA, Wright PE.

J Mol Biol. 1991 Sep 20;221(2):533-55.

PMID:
1920431
12.
13.

High-resolution three-dimensional structure of reduced recombinant human thioredoxin in solution.

Forman-Kay JD, Clore GM, Wingfield PT, Gronenborn AM.

Biochemistry. 1991 Mar 12;30(10):2685-98.

PMID:
2001356
14.

Locating the unpaired cysteine of tissue-type plasminogen activator.

Sehl LC, Nguyen HV, Berleau LT, Arcila P, Bennett WF, Keyt BA.

Protein Eng. 1996 Mar;9(3):283-90.

PMID:
8736495
16.

Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide.

Xu RX, Word JM, Davis DG, Rink MJ, Willard DH Jr, Gampe RT Jr.

Biochemistry. 1995 Feb 21;34(7):2107-21.

PMID:
7532003
17.

1H NMR structural characterization of a recombinant kringle 2 domain from human tissue-type plasminogen activator.

Byeon IJ, Kelley RF, Llinás M.

Biochemistry. 1989 Nov 28;28(24):9350-60.

PMID:
2558718
18.

Solution structure and backbone dynamics of the human alpha3-chain type VI collagen C-terminal Kunitz domain,.

Sorensen MD, Bjorn S, Norris K, Olsen O, Petersen L, James TL, Led JJ.

Biochemistry. 1997 Aug 26;36(34):10439-50.

PMID:
9265624
19.

The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.

Lamba D, Bauer M, Huber R, Fischer S, Rudolph R, Kohnert U, Bode W.

J Mol Biol. 1996 Apr 26;258(1):117-35.

PMID:
8613982
20.

Supplemental Content

Support Center